Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Phase 3 STELLAR-303 Study - XL092 in Combination With Atezo vs. Regorafenib in Previously Treated mCRC"

33 views
July 2, 2023
0 Comments
Login to view comments. Click here to Login
GI